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Abstract
Background: Mutation of the epidermal growth factor receptor (EGFR) results in a discordant cell signaling, leading to the
development of various diseases. However, the mechanism underlying the alteration of downstream signaling due to such
mutation has not yet been completely understood at the system level. Here, we report a phosphoproteomics-based
methodology for characterizing the regulatory mechanism underlying aberrant EGFR signaling using computational
network modeling.
Methodology/Principal Findings: Our phosphoproteomic analysis of the mutation at tyrosine 992 (Y992), one of the
multifunctional docking sites of EGFR, revealed network-wide effects of the mutation on EGF signaling in a time-resolved
manner. Computational modeling based on the temporal activation profiles enabled us to not only rediscover already-
known protein interactions with Y992 and internalization property of mutated EGFR but also further gain model-driven
insights into the effect of cellular content and the regulation of EGFR degradation. Our kinetic model also suggested critical
reactions facilitating the reconstruction of the diverse effects of the mutation on phosphoproteome dynamics.
Conclusions/Significance: Our integrative approach provided a mechanistic description of the disorders of mutated EGFR
signaling networks, which could facilitate the development of a systematic strategy toward controlling disease-related cell
signaling.
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Introduction
EGFR is a receptor tyrosine kinase that is widely expressed in
epithelial tissues and plays important roles in information transfer
from extracellular signals to the intercellular region, regulating
many biological activities such as cell proliferation, differentiation,
and survival. There is some evidence that the mutation of EGFR
triggers the deregulation of the EGFR signal transduction system
and is strongly associated with abnormal cell behavior [1,2].
Therefore, the necessity to gain a deeper insight into mutation-
initiated aberrant signaling has emerged as a major concern to
understanding the ErbB signaling networks. However, the
mechanism by which EGFR mutation alter downstream signaling
is not yet completely understood at the system level mainly
because of the absence of established methodologies to generate
and analyze quantitative information on mutant EGFR signaling
on a network-wide scale. Thus, an integrated platform is required
for evaluating the system-level properties of cell-specific signaling
dynamics.
In recent years, there have been great improvements in
proteome analysis using tandem mass spectrometry coupled with
liquid chromatography (LC-MS/MS) technology, thereby en-
abling large-scale identification of peptides and some types of
protein modifications [3,4]. Moreover, the establishment of
protein labeling methods has enabled the quantitative measure-
ment of proteins and peptides in samples on a proteome-wide scale
[5,6]. Recent time-course activation data from the LC-MS/MS
experiments have provided a global view of EGFR signal
transduction systems [7], accelerating system-level understanding
of signal processing based on numerical and statistical analyses [8–
13].
Because the complexity of biological networks prevents the
intuitive understanding of signaling networks, many numerical
representations of signal transduction, particularly in the ErbB
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13926signal transduction system, have also been investigated [14–27]. In
our recent study, we constructed a numerical model of EGFR
signaling based on the hybrid functional Petri net with extension
(HFPNe) [25]. HFPNe is a computational modeling architecture
that can describe not only continuous events but also discrete
events [28–32] and enables the analysis of temporal data on
biological entities within the data assimilation framework [33–35].
The data assimilation framework was originally developed and
successfully implemented in geophysics to predict geological
phenomena such as El Nino-Southern Oscillation by integrating
a high-dimensional computational model and limited observed
data [36] and is considered to be applicable for the construction of
a reliable signal transduction model using time-dependent
phosphoproteomic data.
EGFR signal transduction is initiated by receptor autopho-
sphorylation triggered by ligand binding. Phosphorylated EGFR
(pEGFR) serves as an adaptor for cellular proteins that can
recognize phosphorylated tyrosine residues and subsequently
catalyzes tyrosine phosphorylation of recruited proteins. Recently,
comprehensive in vitro analyses of binding proteins for each
autophosphorylation site in the ErbB family receptors were
conducted using mass spectrometry and protein microarray [37–
39]. The results from the protein microarray analysis indicated
that phosphorylated Y992 (pY992) bound to multiple cellular
proteins, serving as a multifunctional docking site of EGFR [38].
Under in vivo conditions, Y992 has been shown to bind to several
EGF signaling modulators such as phospholipase C gamma 1
(Plcc1) [40], Vav2 [41], and RAS p21 protein activator (RasGAP)
[42], and also to act as a dephosphorylation target of protein
tyrosine phosphatase, non-receptor type 1 (PTP1B) [43], and
protein tyrosine phosphatase, non-receptor type 11 (Shp2) [44]. Of
these EGF signaling modulators, Plcc1 and Vav2 are known as
positive regulators of mitogen-activated protein kinase (MAPK)
pathway, whereas RasGAP is known to negatively regulate the
MAPK pathway by enhancing the catalytic activity of Ras.
Therefore, mutation at Y992 of EGFR would be expected to cause
complex bidirectional effects on downstream signaling networks,
and is particularly suitable as a model system to evaluate the
performance of our approach.
Here, we report a novel phosphoproteomics-based framework
to analyze the system-wide effect of single point mutation at Y992
of EGFR. We measured EGF-induced temporal activation of
tyrosine phosphorylation-mediated signaling in two NIH3T3-
derived cells expressing either wild-type EGFR (WT) or mutant
EGFR with substitution of tyrosine to phenylalanine at position
992 (Y992F) (the numbering system excludes the 24 amino acid
signal peptide of EGFR). The phosphotyrosine-dependent pro-
teome dynamics in these two cell types characterized an unbiased
landscape of the aberrant Y992F signaling. On the basis of the
quantitative profiles, our computational modeling approach
described the quantitative differences in EGFR signaling between
WT and Y992F cells, presenting potential factors for generating
the aberrant signaling dynamics.
Results and Discussion
Identification and Quantitation of EGF-Induced
Phosphoproteome in WT and Y992F
To elucidate the global differences in EGF-induced signaling
dynamics between WT and Y992F cells, we performed quantita-
tive proteomic analysis of phosphotyrosine-dependent signaling
molecules. Stable isotope labeling by amino acids in cell culture
(SILAC) was applied for time-dependent comprehensive quanti-
tation of phosphotyrosine-dependent proteins using a nano-flow
LC-MS/MS system as previously described [45] (Figure 1A).
From the eight independent measurements (Figure 1B), 383
peptides were identified and assigned to 147 proteins in total
(Table S1). Relative quantitation of the identified proteins was
performed using the AYUMS algorithm [46] and MSQuant
software [47] (Figure S1, Table S1). For each identified protein,
relative activation values in each measurement were combined
and normalized by that of WT at 5 min of EGF stimulation (Table
S1). In order to extract EGF-dependent molecules of phosphotyr-
osine signaling, we adopted 1.5 as the threshold of fold change for
the time-course activation data on either of the two cells. In this
criterion, 41 proteins were extracted (Table S1) and used for
further computational analyses. Among the 41 proteins, 15
proteins were quantified by a single peptide and 26 proteins were
quantified by multiple peptides (Table S1). All experimental data
were generated for this study using the methods described in our
prior publication [45].
Figure 1. Strategy for measuring the quantitative behaviors of
EGF-induced tyrosine phosphoproteome in WT and Y992F
cells. A. Flowchart for SILAC experiment. Each cell population encoded
with isotopically labeled arginine (Arg-0, Arg-6, or Arg-10) is stimulated
with EGF for the time intervals indicated. Tyrosine phosphoproteins are
enriched from equally mixed cell lysates using phospho-tyrosine
specific antibodies. The purified complexes were digested in solution
and directly applied to nano-flow LC-MS/MS system for protein
identification and quantitation. B. An experimental design for acquiring
temporal profiles of tyrosine phosphoproteome upon EGF stimulation.
Temporal profiles were generated through integration of eight
independent mass spectrometric measurements. For each time period,
relative quantitative values were normalized to the values for WT at
5 min.
doi:10.1371/journal.pone.0013926.g001
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Proteome Reveal the Global Impact of the Mutation at
Y992
To reveal the differences in signal transduction between the two
cells, we calculated two types of scores—activation score (A)
(Figure 2A) and deviation score (D) (Figure 2B) —which represent
the differences in the amount of phosphotyrosine-dependent
proteins and the deviation of the temporal pattern, respectively
(see Methods section and Table S1). As shown in Figure 2A, the
activation level of most of the proteins was increased or unchanged
in Y992F cells compared to that in the WT cells, although that of
EGFR was slightly decreased. Regarding temporal pattern, a
limited fraction of molecules showed distinct pattern changes
between the two cell types (Figure 2B). Modulators of EGFR
trafficking such as HGF-regulated tyrosine kinase substrate (Hrs),
zinc finger, FYVE domain containing 16 (ZFYVE16), and signal
transducing adaptor molecule (SH3 domain and ITAM motif) 2
(STAM2) showed differences in the peak time or amplitude of
activation; this clearly indicated that Y992F affected the regulation
of the EGFR degradation pathway. Moreover, sustained activa-
tion of extracellular signal-regulated kinase 1 (ERK1) was
remarkably observed in Y992F cells, whereas it was transiently
activated in WT cells. This apparent pattern conversion was not
observed in the upstream positive effectors of ERK1, such as
EGFR, Grb2, Shc, Shp2, and Plcc1.
Construction of EGFR Signal Transduction Model Based
on the HFPNe Architecture
The time-dependent profiles of the EGF-induced phosphopro-
teome measured in the WT and Y992F cells revealed their
qualitative and quantitative differences at the network level. To
elucidate the mechanisms underlying these alterations as a system,
we performed dedicated computational analysis using biochemical
simulation based on the HFPNe architecture. The computational
model for this study was essentially built based on the EGFR
models previously reported [25,26] with some modifications and
extensions using information from published literature (Material
S1). Our HFPNe-based EGFR model consists of sequential
activation of EGF signaling networks from EGF stimulation to
activation of the canonical MAPK cascade (Figure 3). To
investigate the regulatory mechanisms underlying EGFR degra-
dation pathway, we performed detailed modeling of the processes
for ubiquitin modification of EGFR and its sorting from the
plasma membrane compartment to the lysosomal compartment.
The detailed specification of the model is shown in Figure S2,
Table S2, and Table S3 and the electrical format of the model can
be found in Material S2.
The parameters in our EGFR model were optimized using a
sequential Monte Carlo method known as a particle filter as
described previously [33] to generate the temporal activation
dynamics of EGFR, Shc, Plcc1, Hrs, Casitas B-lineage lymphoma
b (Cbl-b), Shp2, and ERK1 measured by quantitative phospho-
proteomics (detailed procedures of parameter estimation can be
found in Material S1 ). Because our model contains many free
parameters, it is extremely difficult to estimate probabilistic
distributions of all parameters simultaneously within a feasible
time. Then, we conducted two-step parameter optimization. In the
first global optimization process, multiple parameters were varied
at the same time within the narrow range to estimate the global
parameter distributions. Next, local parameter distributions were
estimated by applying a particle filter to each parameter within the
broad range, while other parameters were varied according to the
probabilistic distributions obtained by the global optimization
process. We performed global optimization of 102 parameters to
generate the phosphorylation dynamics of EGFR, Shc, Plcc1, Hrs,
Cbl-b, Shp2, and ERK1 in the WT cells. Next, we estimated the
global parameter distributions of the Y992F model on the basis of
those in the WT model. In all, 64 parameters in the WT model
were fixed, and the remaining 54 parameters regarding the initial
abundance of signaling molecules, the binding processes of EGFR
to the related proteins, the phosphorylation processes catalyzed by
EGFR, and the EGFR regulation pathway were varied for further
parameter optimization. Finally, we estimated probabilistic
distribution of each parameter in the WT and Y992F model
(Figure S3). The final simulation results with the estimated
distribution of parameters accurately reproduced the experimental
data on both the WT (RMSE=0.16) and Y992F cells
(RMSE=0.16) (Figure 4).
Verification of the model accuracy
To evaluate the performance of our model, we compared the
significant parameter differences between the WT and Y992F
models with the already known properties of Y992F signaling
described in the literature. We defined 13 of up or down regulated
parameters that satisfy both fold-change$2.0 and p-value#0.001
simultaneously (Table 1). Our model suggested the increase in the
dissociation constants of Plcc1 from pEGFR. This result is
consistent with those of the previous studies indicating that Plcc1
preferentially bind to pY992 [40]. Regarding EGFR internaliza-
tion dynamics, Y992F mutation is known to increase the rate of
Figure 2. Distinct signal properties regarding WT and Y992F cells. A. The differential phosphorylation status between WT and Y992F cells.
The distribution of the activation score (A) of each protein, which indicates the fold-change of phosphorylation amount of Y992F versus that of WT. B.
The differential phosphorylation dynamics between WT and Y992F cells. The distribution of deviation score (D) of each protein, which indicates the
deviation of the phosphorylation pattern.
doi:10.1371/journal.pone.0013926.g002
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EGFR undergoes internalization more rapidly than Y992-
phosphorylated EGFR [49]. In agreement with the above
biological evidence, our model showed that the EGFR internal-
ization rate was higher in the Y992F model than in the WT model
(Table 1). On the other hand, our model did not clearly indicate
corresponding differences of parameters regarding the interactions
of EGFR with RasGAP and Shc [42,38]. These results would
Figure 3. Schematic representation of HFPNe-based EGFR signal transduction model. Solid-line and dashed-line arrows denote direct
physical interactions and indirect associations or catalytic reactions, respectively.
doi:10.1371/journal.pone.0013926.g003
Figure 4. Comparison of simulation results with experimental data. The solid and dashed lines represent the averaged simulation results
from the WT and Y992F parameter distributions, respectively. The squares and triangles represent the normalized experimental data on WT and
Y992F, respectively. Root mean square error (RMSE) for each protein is indicated.
doi:10.1371/journal.pone.0013926.g004
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data is required for constraining the parameters. Our computa-
tional approach successfully captured a part of the already-known
biological consequences regarding Y992F mutation without over-
interpretation of the experimental data.
Parameter-Based Discovery of the Critical Reactions
Governing Cell-Specific Signaling
In the complex biological system, there are robust and fragile
parameters against the system behavior [50]. Hence, the
magnitude of fold change between the two models does not reflect
the importance of the parameters themselves. Thus, we evaluated
the importance of the 38 parameters that showed significant
difference (p-value#0.001) between the WT and Y992F models
on the basis of phenotypical impact. Each of the parameters in the
Y992F model was reset to the value in the WT model. Next, we
calculated the likelihood of the model to the observed activation
levels, which we termed as local parameter influence (LPI)
analysis. The result of our analysis revealed that most of the
parameters had a small effect on the re-simulation results, whereas
a few parameters had a great impact on the system behavior
(Figure 5, Table S4). Of the evaluated parameters, 12 parameters
mainly governed the activation dynamics of all the observed
proteins in the Y992F model. Of these 12 parameters, 6 defined
the initial abundance of EGFR, Src, Shp2, Grb2, Cbl, and growth
factor receptor bound protein 2-associated protein 1 (Gab1); 4
indicated the phosphorylation rates of Shc, Gab1, Shp2 and Plcc1;
and 2 indicated the binding constant of Grb2 to pEGFR and the
rate of EGFR ubiquitination.
Effect of Cellular Content on EGF Signaling Dynamics
With regard to initial protein abundance, the magnitude of fold
change between the two models was relatively small, but it had
more effect on the simulation results than those of the other
parameters. Then, we measured the differences in the total protein
abundance of EGFR, c-Cbl, Cbl-b, Grb2, Src family kinases
(SFKs), Shp2, Shc, and Erk1/2 between WT and Y992F cells in
order to compare the results with those predicted by the in silico
model. This analysis revealed that almost all the protein species,
except SFKs, showed good correlations (Pearson’s correlation
coefficient=0.94, p-value=0.002) between in silico and in vivo
(Figure 6A). These results strongly suggest that the distinct Y992F
cell signaling dynamics depend on the differences in cellular
context between the two cells to some extent. Next, we further
Table 1. Up or down regulated parameters with at least two-
fold change of the mean value for each parameter
distribution (p-value less than 0.001).
Description Log2-fold change
Up-regulated parameter
EGFR internalization* 4.1
Shp2_phosphorylation 3.6
EGFR_ubiqutination 3.0
EGFR_Plcc1_dissociation* 2.1
Shc_phosphorylation 1.5
PI3K_abundance 1.1
Gab1_phosphorylation 1.1
EGFR_deubiquitination 1.1
Down-regulated parameter
EGFR_dimer_dissociation 21.5
EGFR_binding 21.1
Parameters associated with the literature are indicated with an asterisk.
doi:10.1371/journal.pone.0013926.t001
Figure 5. Parameter-based discovery of the critical reactions
governing Y992F signaling. Each of the 38 estimated parameters in
the Y992F model was reset to the value in the WT model, and the
likelihood for the measured data was evaluated. The color bar shows
the log-transformed fold change of the likelihood against the value in
the original Y992F model. The likelihood for all the observed data was
calculated as a geometric average of the likelihood for the data for each
protein. The likelihood regarding the WT and Y992F models is indicated
as positive and negative controls, respectively.
doi:10.1371/journal.pone.0013926.g005
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dynamics of Y992F by using our EGFR model. The parameters
that define the initial abundance of biological species in the WT
model were randomly varied between 0.1 and 10 fold in order to
reproduce the temporal activation data on Y992F cell signaling.
Constrained Y992F model estimation revealed that the alterations
in the total protein abundance alone could not completely
reproduce the signal dynamics of Y992F (RMSE=0.54)
(Figure 6B). Thus, we speculated that the reactions defined by
the other six parameters were mainly governed by pY992 in the
short-term EGFR signaling.
Model Prediction Reveals Quantitative Differences in
EGFR Degradation Pathway
Our LPI analysis revealed that the increase in EGFR
ubiquitination rate in Y992F model only influenced Cbl and Hrs
(Figure 5), which are EGFR degradation-related molecules that
showed distinct temporal activation patterns between WT and
Y992F cells. Therefore, we examined the quantitative differences
in the ubiquitin-dependent EGFR degradation pathway between
the two cells by using our EGFR model. EGFR monoubiquitina-
tion is catalyzed by activated Cbl family proteins, thereby
facilitating the lysosomal degradation of EGFR [51]. We have
Figure 6. Analysis of the effect of the cellular content on EGF signaling dynamics. A. Experimental validation of relative expression level of
model species. Upper right panel: predicted parameter value regarding the initial concentration of model species. Error bars represent standard
deviations of 1,000 samples from an ensemble of the WT and Y992F models. Left and lower right panel: western blot analysis of relative concentration
of model species. Unstimulated cell lysates of the WT and Y992F cells were dissolved by SDS-PAGE and probed using anti-EGFR, anti-Cbl, anti-Cbl-b,
anti-Grb2, anti-Src, anti-Shp2, anti-Shc, anti-Erk1/2, and anti-b-tubulin as a loading control. Quantitated band intensities were normalized to the
values for WT. With regard to Shc and Erk proteins, the intensities of three bands of Shc isoforms and two bands of Erk1 and Erk2 were combined,
respectively, for the calculation of the relative protein amount. Error bars represent standard deviations of triplicate samples. *P,0.05 (unpaired t-
test). B. The simulation results with the best estimated parameters regarding molecular abundance. We performed constrained parameter estimation
where the abundance of all the model species was allowed to change within 0.1–10 fold. The parameter set with 1.1610
26 of the likelihood was
selected as the best one through 60 steps of calculation. The solid line represents the simulation results of the model with the best parameters. The
squares represent the experimental data on the Y992F cells.
doi:10.1371/journal.pone.0013926.g006
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expression level of EGFR and Cbl family proteins—c-Cbl and
Cbl-b—in Y992F cells (Figure 6A). This would probably affect the
amount of EGFR-bound Cbl. Our model predicted the decrease
in EGFR-bound Cbl per EGFR in Y992F cells compared to that
in the WT cells; this result was then validated by measuring the
level of Cbl-b co-immunoprecipitated with EGFR (Figure 7A).
Note that c-Cbl was not sufficiently detected in the same sample.
These results indicate that Cbl-b has dominant functions for
EGFR signaling in our cell lines, which is also supported by the
evidence that the number of mass detectable peptides derived from
c-Cbl was fewer than that of Cbl-b (Table S1). Because Cbl-b is a
ubiquitin ligase of EGFR, this decrease was considered to induce a
decrease in the amount of ubiquitinated EGFR in the Y992F cells.
Contrary to our intuitive prediction, however, increase in the
amount of ubiquitinated EGFR was observed in the Y992F model
(Figure 7B), which resulted in rapid EGFR degradation
(Figure 7C). These counterintuitive predictions were all success-
fully validated in the corresponding experiments (Figure 7B, C).
These results indicate that the increase in EGFR ubiquitination
rate is responsible for the alterations in EGFR degradation
pathway in Y992F cells and further suggest that the amount of
Y992F ubiquitination does not correlate with the amount of
EGFR-bound Cbl-b. There are some direct or indirect mecha-
nistic explanations that should be considered regarding the
relationships between EGFR mutation and the increase in EGFR
ubiquitination rate in the Y992F model. The former suggest that
EGFR mutation changes the receptivity of ubiquitination or that
un-modeled factors such as other components in the ubiquitina-
tion system or deubiquitinating enzymes are regulated by the
Y992 residue of EGFR. The latter could be supported by the
Signaling Flux Redistribution (SFR) concept [52], which indicates
that if one pathway is enhanced or impaired at the pathway
branches, an alternative pathway is down-regulated or enhanced
because the total signaling flux in a pathway junction is conserved.
One of the possible mechanisms along with the SFR concept is
that if there exist any novel positive regulators of EGFR
ubiquitination that bind to EGFR, impairment of other proteins
binding to EGFR can redistribute the positive signaling flux to the
EGFR ubiquitination pathway. Another explanation is also
Figure 7. Comparison of in silico (left) with in vivo (right) dynamics of EGFR degradation pathway. A, B. The temporal dynamics of
EGFR-bound Cbl-b and ubiquitinated EGFR. Extracted proteins were normalized to the initial expression amount of EGFR, and then subjected to EGFR
immunoprecipitation. Immunoblottings were performed to detect co-immunoprecipitated Cbl-b and ubiquitinated EGFR. Error bars represent the
deviations of two independent experiments. The simulated results were normalized to the initial abundance of EGFR predicted in silico. C. The
temporal dynamics regarding the total amount of EGFR. EGF-stimulated cell lysates were applied to immunoblots to detect total EGFR protein. Band
intensities and simulated results were normalized to the value at zero time point for each cell type. Error bars represent standard deviations of three
independent experiments. The raw data on the immunoblot experiments can be found in Figure S4.
doi:10.1371/journal.pone.0013926.g007
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tion process. In our model, Cbl catalyzes ubiquitination of all non-
ubiquitinated EGFR in the phosphorylated state, irrespective of
whether signaling proteins bind to EGFR or not. Thus,
diminishing protein binding to EGFR promoted the dephosphor-
ylation of EGFR because the level of free EGFR, with which
phosphatases can interact, was increased, resulting in the decrease
of Cbl-substrate EGFR. However, if the binding of proteins to
EGFR inhibits the catalyzation of EGFR ubiquitination and only
free EGFR acts as the substrate of Cbl, decreased protein binding
to the mutated EGFR would promote efficient EGFR ubiquitina-
tion due to the increase in the amount of free EGFR.
Enhancement of Phosphorylation Rate Is Essential for
Reproducing Y992F Dynamics
Our computational model-based analyses indicated that the most
obvious characteristic feature of Y992 signalingis the increase in the
efficiency of the phosphorylation processes across the network
(Figure 5). Since phosphorylation efficiency is determined by the
balance between the rates of phosphorylation and dephosphoryla-
tion, there is a possibility that the decrease in dephosphorylation
rate can also reproduce the dynamics of Y992F signaling. To clarify
the aberrant processesinthe Y992F cell, we re-estimated the Y992F
model from the WT model by changing the parameters including
both or either of the two processes. In all, four different
combinations of parameters (Type 1–4) were estimated by data
assimilation to reproduce the temporal activation data on Y992F,
where the remaining parameters were fixed at the values in the WT
model. Type 1 indicates an original combination of 54 parameters,
which isthe hypothesized modelinwhichboth phosphorylation and
dephosphorylation are altered in the Y992F cell. Types 2 and 3 did
not include the parameters for dephosphorylation and phosphor-
ylation processes, respectively. These models were used to test the
hypothesis that either of process is not affected by Y992F mutation.
For Type 4 as a negative control, the parameters for both the
processes were unchanged. Figure 8 shows the likelihood distribu-
tion of the best models from the 10 independent parameter
estimation experiments using each type of parameter sets (the
likelihood and the value of each parameter set can be found in
Table S5). Type 2 retained the same degree of likelihood as that of
Type 1, whereas Type 3 showed a significant decrease in the
likelihood to the same extent as that of Type 4. Notably, Types 3
and 4 could not reproduce the enhancement of the activation level
of Shp2 and the sustained activation of ERK (Figure S5). These
results indicate that the increase in phosphorylation rates is essential
for Y992F signaling in our model.
Although the direct interpretation for the increase in phosphor-
ylation rates is that Y992F mutation increases the intrinsic tyrosine
kinase activity of EGFR, it is however reported to remain
unchanged by the mutation of Y992 [48]. This evidence strongly
suggests the contribution of some extrinsic factors that need to be
modeled, such as unknown kinase inhibitors like Mig6 [53,54], or
the alteration of the substrate specificity of EGFR caused by the
mutation [55]. An alternative possibility could be the involvement
of SFKs that are highly associated with EGF-induced tyrosine
phosphoproteome [45]. Because we assumed that the phosphor-
ylation of each molecule is defined by a single upstream kinase in
our model (Figure 3 and S2), estimation of the contribution of
multiple kinases to respective phosphorylation processes was
difficult. There was a large discrepancy regarding the abundance
of SFKs between the in silico prediction and the in vivo
measurement, indicating that the model for SFKs in EGF
signaling is incomplete. Therefore, more sophisticated models
containing not only inhibitory molecules but also the complex
involvement of multiple kinases are required for further clarifica-
tion of the regulatory mechanisms underlying the increase in the
phosphorylation rate on a network-wide scale.
Conclusion
Our study reported a phosphoproteomics-based framework for
providing a mechanistic view of aberrant signaling initiated by a
mutated receptor. The low-biased quantitative data on EGF-
induced tyrosine-phosphoproteomerevealed a network-wide en-
hancement in phosphotyrosine signaling, alteration in EGFR
degradation pathway, and aberrant temporal activation of ERK1
in the Y992F cells. Furthermore, our EGFR signaling model based
on the HFPNe architecture enabled reduction of the factors
responsible formutationaleffecttoseveralalterations inthereaction
parameterswithconsiderationfordifferentcellularcontexts.Model-
based analyses indicated that Y992F mutation caused rapid EGFR
degradation through the up-regulation of EGFR ubiquitination and
aberrant temporal activation of ERK1 by network-wide activation
of tyrosine-phosphorylation; this suggests that pY992 strengthens
and attenuates phosphotyrosine singling by distinct regulatory
mechanisms. By applying our approach to disease-associated
genetic alterations of signaling molecules, it will be possible to
mechanistically describe the disorders of their cell signaling
networks at the system level. Mass spectrometry-based quantitative
phosphoproteomics, combined with computational network mod-
eling, will enable the theoretical representation of potential
therapeutic strategies for adjusting aberrant network behaviors.
Materials and Methods
SILAC Experiment
WT and Y992F cells expressing full-length human EGFR (WT)
and mutant EGFR with substitution of tyrosine to phenylalanine
Figure 8. The enhancement of the phosphorylation rate is
essential to reproduce the dynamics of Y992F signaling
networks. Parameter estimation for the Y992F model was performed
using different combinations of parameters indicated in the lower box
(Types 1–4). Type 1 contains all 54 parameters, Type 2 contains 40
parameters without dephosphorylation processes, Type 3 contains 49
parameters without phosphorylation processes, and Type 4 contains 35
parameters without both phosphorylation and dephosphorylation
processes. For each parameter combination, 10 independent parameter
estimation processes were performed with 60 steps per process
through data assimilation. The y-axis indicates the likelihood distribu-
tion of the best model within each process, while the x-axis indicates
the types for parameter combinations.
doi:10.1371/journal.pone.0013926.g008
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amino acid signal peptide of EGFR), respectively, were maintained
and used according to our previous study [56]. SILAC
experiments were carried out as described previously [45,57].
Briefly, WT and Y992F cells were labeled with L-arginine (Arg-0),
L-arginine-U-13C6 (Arg-6), or L-arginine-U-13C6-15N4 (Arg-10).
After overnight starvation, each cell population (5610-cm dishes
per condition) was stimulated with 150 ng/ml of EGF for the
indicated time intervals. The cells were washed three times with
cold phosphate buffered saline (PBS) and then lysed in TNE buffer
containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP40,
0.1% sodium deoxycholate, 1 mM Na3VO4, and protease
inhibitor cocktail (Roche Diagnostics). The protein concentration
of cell extracts was quantified using the bicinchoninic acid (BCA)
assay (Pierce Chemical Co.), according to the manufacturer’s
instructions. The cell lysates were mixed in ratios of 1:1:1 and
2:1:1 (Arg-0:Arg-6:Arg-10) in experiments 1–5 and in experiments
5–8, respectively, and then subjected to immunoprecipitation
process. Tyrosine phosphoproteins were captured using anti-
phosphotyrosine antibodies (4G10; Upstate and pTyr100; Cell
Signaling Technology) and eluted with 25 mM of phenyl
phosphate. The eluted proteins were digested by trypsin (Roche
Diagnostics) overnight at 37uC, followed by purification with Zip-
Tip C18 (Millipore).
Mass Spectrometry Measurement
The purified peptide mixtures were analyzed using a high-
resolution nanoflow reversed-phase liquid chromatography cou-
pled with quadrupole time-of-flight tandem mass spectrometer (Q-
Tof-2; Micromass Ltd.), as described previously [45]. The MS/
MS signals were then converted to text files by MassLynx (version
3.5, Micromass) under the default parameter settings. The peak
lists were searched against the RefSeq mouse (45,347 sequences;
July 3, 2006) and human (33,506 sequences; June 25, 2007)
sequences using Mascot software (version 2.2; Matrix Science)
with a mass tolerance of 500 ppm for parent peptide ions and
0.5 Da for fragment ions. The peptides were constrained to be
tryptic with a maximum of three missed cleavages. Acetylation of
N-terminal residues; oxidation of methionine residues, Arg-6, Arg-
10; and formation of pyroglutamic acid for peptides containing an
N-terminal glutamine were considered as variable modifications.
Protein identification was based on the criterion of having at least
one MS/MS data with Mascot scores that exceeded the thresholds
(p,0.05). The annotated MSMS spectra of peptides used for
single peptide identification can be found in Material S3. If a
subset of peptides was matched to multiple proteins, the protein
that was supported by the most peptides over the eight mass
spectrometric measurements was selected as the representative. A
randomized decoy database generated by Mascot program
estimated a false discovery rate at 0.09% for all the identified
peptides. Regarding the proteins identified, quantitation was made
on the basis of the mass spectra of SILAC-encoded peptides with
Mascot scores (§20) using the AYUMS algorithm [46] and the
MSQuant software (version 1.4.0a16) [47]. Pearson’s correlation
coefficient between the duplicate measurements of Y992F and WT
(Exps. 3–5 versus Exps. 6–8 in Figure 1B) using the independent
SILAC-encoded cell populations were calculated as 0.90,
indicating good biological reproducibility. To combine the
duplicate time-series data regarding Y992F cell signaling, the
average value of two time-series data normalized to the value at
5 min of Y992F activation were multiplied by the ratio of Y992F
to WT activation at 5 min. For the proteins for which the value at
5 min was not measured in Exp. 8 (Figure 1B), either value of
1 min or 20 min was used for normalization. The procedures for
protein identification and quantitation were strictly compliant with
those reported previously [45].
Functional Scoring
Differential activation profiles of EGFR downstream pathways
were characterized on the basis of the fold change of phosphotyr-
osine-dependent proteins and the deviation of time-dependent
activation patterns between the two cells. The activation score A of
each protein is defined as
A~
log2
mY992F t1 ðÞ
mWT t1 ðÞ, n~1
log2
P n{1
i~1
mY992F ti ðÞ zmY992F tiz1 ðÞ ðÞ | tiz1{ti ðÞ fg
P n{1
i~1
mWT ti ðÞ zmWT tiz1 ðÞ ðÞ | tiz1{ti ðÞ fg
, n~3,5
8
> > > > > > <
> > > > > > :
where mWT(ti) and mY992F(ti) denote the relative quantitative
values at the time point of ti with regard to WT and Y992F,
respectively, which were normalized to the values for WT at
5 min. The activation score A represents the ratio of the area
under the curve of temporal dynamics data on the Y992F cells to
that on the WT cells.
The deviation score D of each protein is defined as
D~
1
n
X n
i~1
nY992F ti ðÞ {nWT(ti) ðÞ
2, n~3,5
where nWT(ti) and nY992F(ti) denote the relative quantitative values
at the time point ti with regard to WT and Y992F, respectively,
which were each normalized to the values at 5 min. The
calculated scores are indicated in Supplementary information
(Table S1).
Biochemical Simulation Analysis
Cell Illustrator Online (version 4.0; GNI) was used for
constructing and performing simulation with 10-ms time-steps on
our EGFR signal transduction model. Parameter optimization was
performed on the basis of particle filtering to estimate an ensemble
of the WT and Y992F models [33] (see Supplementary Text). In
order to compare the experimental data with the corresponding
simulation results, the SILAC experiment data were normalized by
the following procedures. First, the temporal data on each protein
werenormalized by the value for WT at 5 min. Second, the value at
time zero for each protein was subtracted from the values at all the
time points. Finally, the value at each time point was renormalized
by the value for WT at 5 min. Statistical analyses were performed
using the R software (version 2.11.1). We used Welch’s t-test for
comparison of parameter distributions between the WT and Y992F
models. Bonferroni correction was applied to adjust the p-values.
Computing time was provided by HA8000 cluster system, Super-
computing Division, Information Technology Center, the Univer-
sity of Tokyo.
Western Blot Analysis
WT and Y992F cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal
bovine serum and antibiotics at 37uCi n5 %C O 2. The cells
treated with EGF (150 ng/ml) were lysed in TNE buffer. The total
cell lysates were mixed with 56 Laemmli buffer and boiled for
5 min at 100uC. For western blotting of EGFR-bound Cbl-b and
ubiquitinated EGFR, the total cell lysates were immunoprecipi-
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for 1 h. The immunocomplexes were recovered on protein G-
agarose (Roche Diagnostics) by incubating overnight at 4uC. After
the purified complexes were washed three times with lysis buffer,
they were solubilized in Laemmli buffer, followed by boiling for
5 min at 100uC. Protein samples were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred to polyvinylidene difluoride (PVDF) membranes.
After the membranes were blocked in 3% bovine serum albumin/
TBS-Tween 20 (TBS-T) at 4uC overnight, they were washed in
TBS-T and incubated with the following primary antibodies at
room temperature for 1 h: EGFR (sc-03; Santa Cruz Biotechnol-
ogy), Cbl (sc-170; Santa Cruz Biotechnology), Cbl-b (sc-8006;
Santa Cruz Biotechnology), mono ubiquitin (MMS-258; Cov-
ance), Shp2 (3752; Cell Signaling Technology), Shc (610081; BD
Transduction Laboratories), Grb2 (610111; BD Transduction
Laboratories), Src (2109; Cell Signaling Technology), Erk1/2
(9102; Cell Signaling Technology), and b-tubulin (T5293;
SIGMA). The membranes were then washed three times with
TBS-T and incubated with horseradish peroxidase (HRP)-
conjugated secondary antibodies at room temperature for 1 h.
The membranes were washed three times with TBS-T, developed
using Immobilon Western (Millipore) and detected by Las3000
mini (FujiFilm). Quantification of the band intensities and back
ground subtraction were conducted using Multi Gauge software
(version 3.0; FujiFilm).
Supporting Information
Figure S1 Representative mass spectra of SILAC-encoded
peptide. Mass spectra of the SILAC-encoded peptide YLVIQG-
DER from the epidermal growth factor receptor isoform a
observed in each experiment are shown. In experiments 1–5, the
SILAC-encoded cell lysates were mixed in a ratio of 1:1:1 (Arg-
0:Arg-6:Arg-10), while in experiments 6–8, 5 min of EGF-
stimulated cell lysate from Arg-0-encoded WT cells was mixed
with Y992F cell lysates in a ratio of 2:1:1 (Arg-0:Arg-6:Arg-10) to
ensure the identification of WT-enriched peptides.
Found at: doi:10.1371/journal.pone.0013926.s001 (0.82 MB TIF)
Figure S2 The reaction scheme of the EGFR signal transduction
pathway. Single- and double-sided solid-line arrows denote
irreversible and reversible state changes, respectively. Dashed-line
arrows denote catalytic reactions or indirect association. Double
solid-head arrows denote summation into a sigma-state. E, EGF;
Er, EGFR; Er2, EGFR dimer; G, Grb2; S, Shc; R, RasGAP; H,
Shp2; P, Plcc1; O, Sos; C, Cbl; A, Gab1; I, PI3K; Hr, Hrs; Sr,
Src; P2, PIP2; P3, PIP3; RsD, RasGDP; RsT, RasGTP; W,
degradation; @EX, at extracellular compartment; @PM, at
plasma membrane compartment; @E, at endosomal compart-
ment; @L, at lysosomal compartment. Sigma denotes summation
of each state; p denotes tyrosine phosphorylation; ub denotes
ubiquitination; pt denotes serine/threonine phosphorylation;
* denotes activation; and a dot denotes binding. [ ] denotes
additional modification of the molecule. {,} denotes alternative
condition of the molecule. The numbers attached to the arrows
represent the reaction indexes indicated in Table S2B.
Found at: doi:10.1371/journal.pone.0013926.s002 (0.78 MB TIF)
Figure S3 Parameter distributions of the WT and Y992F
models. Probability densities of the model parameters were
estimated using kernel density estimation based on an ensemble
of WT and Y992F models. Mean of each ensemble and p-value
obtained from unpaired t-test adjusted by Bonferroni method were
indicated.
Found at: doi:10.1371/journal.pone.0013926.s003 (1.37 MB
PDF)
Figure S4 Western blot analysis of the EGF signaling molecules.
A. The temporal dynamics of EGFR-bound Cbl-b and ubiquiti-
nated EGFR. WT and Y992F cells were stimulated with 150 ng/
ml of EGF for the time intervals indicated. Extracted proteins were
normalized to the initial expression amount of EGFR, and then
subjected to EGFR immunoprecipitation. Immunoblotting was
performed to detect ubiquitinated EGFR and co-immunoprecip-
itated Cbl-b. B. Measurement of EGF-induced degradation of
EGFR. WT and Y992F cells were stimulated with 150 ng/ml of
EGF for the time intervals indicated. Extracted protein samples
were dissolved by SDS-PAGE probed using anti-EGFR and anti-
b-tubulin antibodies as a loading control.
Found at: doi:10.1371/journal.pone.0013926.s004 (0.66 MB TIF)
Figure S5 The simulation results of the best model estimated
using the different combinations of parameters (Types 1–4). The
solid lines represent the simulation results of the model
corresponding to each parameter type indicated in Figure 8.
The squares represent the experimental data on the Y992F cells.
Found at: doi:10.1371/journal.pone.0013926.s005 (1.06 MB
TIF)
Table S1 Results of the SILAC experiments.
Found at: doi:10.1371/journal.pone.0013926.s006 (0.16 MB
XLS)
Table S2 EGFR model description.
Found at: doi:10.1371/journal.pone.0013926.s007 (0.08 MB
XLS)
Table S3 Model parameters.
Found at: doi:10.1371/journal.pone.0013926.s008 (0.10 MB
XLS)
Table S4 Results of the LPI analysis.
Found at: doi:10.1371/journal.pone.0013926.s009 (0.03 MB
XLS)
Table S5 Parameter estimation experiments using different
combinations of parameters.
Found at: doi:10.1371/journal.pone.0013926.s010 (0.08 MB
XLS)
Material S1 Supplementary Materials and Methods
Found at: doi:10.1371/journal.pone.0013926.s011 (0.06 MB
DOC)
Material S2 Electronic format files of EGFR model.
Found at: doi:10.1371/journal.pone.0013926.s012 (0.15 MB ZIP)
Material S3 Annotated MSMS spectra of peptides used for
single peptide identification.
Found at: doi:10.1371/journal.pone.0013926.s013 (4.19 MB
PDF)
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